The persistence of latent reservoirs of HIV-1 represents a major barrier to virus eradication in patients treated with antiretrovirals. Prostratin is a non-tumor promoting 12-deoxyphorbol monoester capable of up-regulating viral expression from latent provirus and therefore is potentially useful for HIV adjuvant therapy and similar properties might be elicited by related non-tumor promoting phorboids. We have therefore investigated a series of phorbol 13- ...
![(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-3-(Acetoxymethyl)-4a,7b,9-trihydr oxy-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro- 9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate Structure](https://image.chemsrc.com/caspic/255/41621-85-6.png)
